These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 20190804)

  • 1. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
    Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
    Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
    Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
    J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
    Ferrer CM; Lu TY; Bacigalupa ZA; Katsetos CD; Sinclair DA; Reginato MJ
    Oncogene; 2017 Jan; 36(4):559-569. PubMed ID: 27345396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
    Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
    Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
    Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.
    Zeng J; Wang L; Li Q; Li W; Björkholm M; Jia J; Xu D
    J Pathol; 2009 Aug; 218(4):419-27. PubMed ID: 19235838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA.
    Wang M; Gartel AL
    Oncotarget; 2011 Dec; 2(12):1218-26. PubMed ID: 22203467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc transferase regulates p21 protein levels and cell proliferation through the FoxM1-Skp2 axis in a p53-independent manner.
    de Queiroz RM; Moon SH; Prives C
    J Biol Chem; 2022 Sep; 298(9):102289. PubMed ID: 35868563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.
    Angelova M; Ortiz-Meoz RF; Walker S; Knipe DM
    J Virol; 2015 Aug; 89(16):8474-83. PubMed ID: 26041297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients.
    Kamigaito T; Okaneya T; Kawakubo M; Shimojo H; Nishizawa O; Nakayama J
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):18-22. PubMed ID: 24366413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells.
    Akella NM; Le Minh G; Ciraku L; Mukherjee A; Bacigalupa ZA; Mukhopadhyay D; Sodi VL; Reginato MJ
    Mol Cancer Res; 2020 Apr; 18(4):585-598. PubMed ID: 31974291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells.
    Wang Z; Banerjee S; Kong D; Li Y; Sarkar FH
    Cancer Res; 2007 Sep; 67(17):8293-300. PubMed ID: 17804744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.
    Kim M; Kim YS; Kim H; Kang MY; Park J; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Park JK; Cho JW; Shin JK; Choi WS
    Oncotarget; 2016 Jul; 7(28):44596-44607. PubMed ID: 27331873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
    Forma E; Jóźwiak P; Ciesielski P; Zaczek A; Starska K; Bryś M; Krześlak A
    PLoS One; 2018; 13(6):e0198351. PubMed ID: 29864144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.